93.85
Schlusskurs vom Vortag:
$91.23
Offen:
$87.6
24-Stunden-Volumen:
1.16M
Relative Volume:
0.66
Marktkapitalisierung:
$5.84B
Einnahmen:
$409.48M
Nettoeinkommen (Verlust:
$-81.28M
KGV:
-70.64
EPS:
-1.3286
Netto-Cashflow:
$-95.14M
1W Leistung:
+3.55%
1M Leistung:
+13.25%
6M Leistung:
+126.64%
1J Leistung:
+161.79%
Twist Bioscience Corp Stock (TWST) Company Profile
Firmenname
Twist Bioscience Corp
Sektor
Branche
Telefon
800-719-0671
Adresse
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs TMO, DHR, IDXX, NTRA, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
TWST
Twist Bioscience Corp
|
93.85 | 5.68B | 409.48M | -81.28M | -95.14M | -1.3286 |
|
TMO
Thermo Fisher Scientific Inc
|
532.48 | 201.86B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
203.83 | 145.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
567.44 | 45.44B | 4.45B | 1.10B | 1.06B | 13.59 |
|
NTRA
Natera Inc
|
271.39 | 38.64B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
A
Agilent Technologies Inc
|
131.46 | 38.44B | 7.23B | 1.41B | 1.09B | 4.979 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-04 | Eingeleitet | Stephens | Overweight |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-06-04 | Eingeleitet | Guggenheim | Buy |
| 2024-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-27 | Eingeleitet | Berenberg | Buy |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-29 | Eingeleitet | William Blair | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Neutral |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-02-05 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-10-20 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2018-11-26 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Twist Bioscience Corp Aktie (TWST) Neueste Nachrichten
Lobbying Update: $82,500 of TWIST BIOSCIENCE CORPORATION lobbying was just disclosed - Quiver Quantitative
Twist Bioscience plans 8 a.m. ET call for fiscal Q3 update - Stock Titan
TWST Maintained by Canaccord Genuity -- Price Target Raised to $120 - GuruFocus
Form 4 Twist Bioscience Corp For: 13 July By Investing.com - Investing.com Nigeria
Twist Bioscience CFO Adam Laponis sells $226,307 in stock - Investing.com
[Form 4] Twist Bioscience Corp Insider Trading Activity - Stock Titan
Form 144 Twist Bioscience Corp For: 9 July By Investing.com - Investing.com Australia
Officer reports multiple common stock sales (NASDAQ: TWST) - Stock Titan
Evercore ISI Raises its Price Target on Twist Bioscience (TWST) - Insider Monkey
Twist Bioscience2026 Funding Rounds & List of Investors - Tracxn
Twist Bioscience stock falls as investors digest recent dilution risk and insider sale signals - Quiver Quantitative
TWST Downgraded by Evercore ISI Group -- Price Target Raised to $102 - GuruFocus
The Power of Complex Gene Synthesis - the-scientist.com
Investment bank Evercore ISI has adjusted its rating on biotechnology company Twist Bioscience Corp (TWST). - Bitget
TWSTTwist Bioscience Corp Options - Finviz
Twist Bioscience Corp. Actuals & Estimates (SWB:0ME) - TradingView
Twist Bioscience stock hits 52-week high at 104.31 USD By Investing.com - Investing.com South Africa
Twist Bioscience stock hits 52-week high at 104.31 USD - Investing.com
Cathie Wood’s ARK sells Twist Bioscience, buys Circle Internet stock - Investing.com
Cathie Wood’s ARK sells Twist Bioscience, buys Circle Internet stock By Investing.com - Investing.com Nigeria
Cathie Wood’s ARK buys Coinbase, sells Twist Bioscience stock By Investing.com - Investing.com Nigeria
Cathie Wood’s ARK buys Coinbase, sells Twist Bioscience stock - Investing.com
TWST Maintained by Guggenheim -- Price Target Raised to $107.00 - GuruFocus
Twist Bioscience Corp. Actuals & Estimates (NASDAQ:TWST) - TradingView
Form 4 Twist Bioscience Corp For: 26 June By Investing.com - Investing.com South Africa
Twist Bioscience CEO Emily Leproust sells $1.79m in stock By Investing.com - Investing.com Nigeria
Insider Sell: Dennis Cho Sells 14,205 Shares of Twist Bioscience Corp (TWST) - GuruFocus
Twist Bioscience CEO Emily Leproust sells $1.79m in stock - Investing.com
Twist Bioscience (TWST) CEO sells 18,880 shares under 10b5-1 plan - Stock Titan
Twist Bioscience (TWST) officer sells 14,205 shares in planned trade - Stock Titan
Twist Bioscience stock rises as investors continue to reward stronger growth outlook and margin progress - Quiver Quantitative
Twist Bioscience Corp. Actuals & Estimates (HAM:0ME) - TradingView
0ME Forecast — Price Target — Prediction for 2027 - TradingView
Form 144 Twist Bioscience Corp For: 25 June By Investing.com - Investing.com Australia
Emily Leproust (TWST) sells blocks of common stock totaling large proceeds in May‑June - Stock Titan
Twist Bioscience SVP Paula Green sells $25,410 in common stock By Investing.com - Investing.com South Africa
Twist Bioscience CEO Emily Leproust sells $147,400 in shares By Investing.com - Investing.com South Africa
Twist Bioscience SVP Paula Green sells $25,410 in common stock - Investing.com UK
Twist Bioscience chief legal officer sells $30,213 in company shares - Investing.com UK
Finanzdaten der Twist Bioscience Corp-Aktie (TWST)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):